Skip to main content
. Author manuscript; available in PMC: 2006 May 25.
Published in final edited form as: Neuropsychopharmacology. 2005 Oct;30(10):1906–1912. doi: 10.1038/sj.npp.1300742

Fig 1.

Fig 1

CRH-stimulated cortisol and ACTH levels (mean ± SE) during hypogonadal (leuprolide plus placebo) and testosterone replaced (leuprolide plus testosterone) conditions in men. Significantly lower stimulated cortisol levels (p < .05) and significantly higher stimulated ACTH levels (p < .05) are seen during testosterone administration.